Petri Karppinen

Petri has over 20 years of startup business and management experience in IT services, software and consulting. As Chief Financial Officer he leads the global operation to prepare the financial management process for growth and business control.
Find me on:

Recent Posts

How Automation Can Impact Testing ROI in 2019

Aug 20, 2019 9:00:00 AM / by Petri Karppinen posted in Network Testing, Automation, Time to Market, Automation ROI

0 Comments

The most obvious benefits of automation for any industry include increased efficiency and decreased reliance on human employees. But for telcos, automation, and particularly automated testing, offers multiple other sources of ROI, from reduced time to market, to better implementation of the Continuous Delivery model.

Read More

How to Measure ROI in Your Test Lab

Jul 18, 2019 3:00:00 PM / by Petri Karppinen posted in Network Quality, 24/7 Regression

0 Comments

In an ideal world, service verification for voice, data, and mobile broadband usage would probably look a lot different than it does right now. Test cycles would be perfectly matched to the timelines for updates, testers would be able to complete tests for the entire range of use cases with time to spare, and any bugs uncovered could be addressed before new updates were rolled out. Unfortunately, that’s not really the world we live in. Instead, we’re stuck with update cycles that are often too short for thorough use case testing, and service verification begins to feel like an unwanted albatross around the neck of any given telco operator.

Read More

What Our 3M Euro Series A Round Means for Our Customers

Jun 27, 2019 8:00:00 AM / by Petri Karppinen posted in Automation, End-to-End Testing

0 Comments

Today, SEGRON announced that it has raised 3M euros in a series A funding round from Credo and OTB. To any of you who have made use of SEGRON’s ATF to automate testing for your networks, devices, or services, we hope this won’t come as too much of a shock. Following a period in which we completed several successful commercialization trials in Germany, Switzerland, Austria, and elsewhere, we demonstrated that our product was truly the most innovative and comprehensive on the market.

Read More